The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment

Author: Duffy S.   Jackson T.L.   Lansdown M.   Philips K.   Wells M.   Pollard S.   Clack G.   Coibion M.   on behalf of the ATAC Trialists’ Group  

Publisher: Oxford University Press

ISSN: 1460-2350

Source: Human Reproduction, Vol.21, Iss.2, 2006-02, pp. : 545-553

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content